Letter from TAG and others asking for withdrawal of mandatory quarantine requirement for entering the US through Newark and JFK airports who have had direct contact with individuals with Ebola Virus Disease in Guinea, Liberia, and Sierra Leone.
Letter from TAG and other advocates expressing concerns about proposed Medicaid criteria that will limit access to sofosbuvir and other lifesaving hepatitis C medications.
Treatment Action Group (TAG) welcomes today’s announcement by the New York State Department of Health (DOH) of the Ending the Epidemic Task Force to more fully develop Governor Andrew Cuomo’s Plan to End AIDS as an epidemic in New York State by the year 2020.
Letter asking to speak to key staff at Novartis to discuss its support of the clinical research required to more fully understand the efficacy of Menveo in adolescents and adults living with HIV.
Generic drug registration, licensing, and a trip to Gilead’s islands Karyn Kaplan and Tracy Swan Access to essential medicines is part of the human right to health. The HIV/AIDS epidemic has demonstrated that generic competition is key to massive antiretroviral…
The basics of generic medications, bioequivalence, and the push for good manufacturing practices Tim Horn Securing access to generic drugs to treat HIV, hepatitis C virus (HCV), and tuberculosis (TB) is now one of the most prominent strategies of global…
Hello Generics: A Drug by Any Other Name; The Road to Treatment Access; Safeguarding Against Stockouts; Generics vs. the Giant
This brief review provides community recommendations for research that requires HIV-positive people to interrupt antiretroviral treatment (ART).
Scientific research into curing HIV infection has expanded significantly in recent years, gaining a much higher profile in the press. Unfortunately, media coverage of cure research can be inaccurate and tends to overhype preliminary results. The purpose of this page…
July 20, 2014 HIV, HCV, and TB Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development Written by Polly Clayden, Simon Collins, Colleen Daniels, Mike Frick, Mark Harrington, Tim Horn, Richard Jefferys, Karyn…